Similarly, our results indicated that LicA has antitumor and antimetastasis effects on human RCC cells, but unlike other reports, we found that LicA induced LC3B expression through modulation of the FAK/Src/Sp1 signaling pathways. This evidence concerns the gene MAP1LC3B and renal cell carcinoma.